Research
Hormonal
Gastroenterologists can play an important role in the management of obesity.
Gastroenterologists should be prepared to manage obesity in their patients.
StrongSupportsmedium confidence
Gastroenterologists can play an important role in the management of this disease.
Why this rating
The claim is based on the context of the obesity pandemic and the role of specialists.
Source
Obesity Primer for the Practicing Gastroenterologist
Pichamol Jirapinyo et al. · The American Journal of Gastroenterology · 2021
DOI 10.14309/ajg.0000000000001200
reviewCited 9×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →